A Study of the Pan-KRAS Inhibitor LY4066434 in Participants With KRAS Mutant Solid Tumors
Eli Lilly and Company
Eli Lilly and Company
Verastem, Inc.
Servier
Pfizer
Eli Lilly and Company
Bristol-Myers Squibb
Genmab
Actuate Therapeutics Inc.
Revolution Medicines, Inc.
TheRas, Inc., d/b/a BBOT (BridgeBio Oncology Therapeutics)
Artios Pharma Ltd
Pfizer
Genfleet Therapeutics (Shanghai) Inc.
Incyte Corporation
Bristol-Myers Squibb
Jazz Pharmaceuticals
Incyte Corporation
Toray Industries, Inc
Trishula Therapeutics, Inc.
NGM Biopharmaceuticals, Inc
IGM Biosciences, Inc.
Eli Lilly and Company
Taiho Pharmaceutical Co., Ltd.
Cantargia AB
Cantargia AB
Eli Lilly and Company
Incyte Corporation
Gilead Sciences
TG Therapeutics, Inc.
Eli Lilly and Company